Anti-nerve growth factor antibodies for the treatment of low back pain
- 2 June 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Clinical Pharmacology
- Vol. 13 (6), 631-639
- https://doi.org/10.1080/17512433.2020.1772052
Abstract
The treatment of chronic low back pain (cLBP) often involves multimodal pharmacologic and non-pharmacologic strategies. There remain shortcomings with these tools with regards to both effect size and side effects. In an effort to better address cLBP, anti-nerve growth factor (NGF) monoclonal antibodies (mAbs) are nearing marketing approval. This class of medications has been primarily evaluated for osteoarthritis, but are being examined at higher doses for use in cLBP. We review the efficacy of this class in treating LBP as well as their potential side effects based on nine phase II or III published clinical trials. Five trials evaluated Tanezumab and four trials evaluated Fasinumab, with seven trials evaluating nonspecific LBP, one evaluating sciatica related cLBP, and one evaluating vertebral fracture related cLBP. The results of available clinical trials indicate modest effectiveness with regard to reduction of pain in the low back, and improved functionality, compared to placebo in keeping with the effect size of other pharmacologic treatment modalities. Rapidly progressive osteoarthritis was infrequently reported. However, the continued observation of this serious side effects warrants careful patient selection and balancing the risks and benefits of anti-NGF mAbs in treating cLBP.Keywords
This publication has 45 references indexed in Scilit:
- Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back painPain, 2013
- Nerve Growth Factor Contribution via Transient Receptor Potential Vanilloid 1 to Ectopic Orofacial PainJournal of Neuroscience, 2011
- Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain?Journal of Anatomy, 2010
- Presence of NGF and its receptor TrkA in degenerative lumbar facet joint specimensEuropean Spine Journal, 2009
- Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritisArthritis Research & Therapy, 2009
- Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samplesJournal of Neurosurgery: Spine, 2008
- Sacroiliac Joint Pain: A Comprehensive Review of Anatomy, Diagnosis, and TreatmentAnesthesia & Analgesia, 2005
- Ondansetron Oral Disintegrating Tablets: Acceptability and Efficacy in Children Undergoing AdenotonsillectomyAnesthesia & Analgesia, 2005
- Retrograde neurotrophin signaling: Trk-ing along the axonCurrent Opinion in Neurobiology, 2002
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001